The Role of DermGEN™ in Achieving Improved Outcomes for Individuals with Diabetic Foot Ulcers: The Science and Clinical Application: Introducing DermGEN™ by RegenMed

Thursday, May 26, 2022
10:00 AM - 11:00 AM

Watch recording

Abstract

Objectives

1. Describe and understand how Diabetes alters the ability of cells to repair injured skin resulting in hard to heal wounds.
2. Introduce DermGEN™—a decellularized and sterile human dermal matrix for wound healing and tissue regeneration.
3. Discuss how DermGEN™ enhances healing and tissue regeneration in hard to heal Diabetic wounds.
4. Describe how DermGEN™ can be used in conjunction with standard wound care practice to facilitate and accelerate the healing of hard to heal Diabetic Foot Ulcers (DFU’s) using examples of clinical treatment and outcomes.